
Earnings call transcript: Reach PLC sees strong performance in H2 2025
Source link
Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial
Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial Source link

Earnings call transcript: Reach PLC sees strong performance in H2 2025
Source link
Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial Source link
Target beats profit outlook, sees sales growth return in 2026 Source link